Product Program year 2020 Source: CMS Open Payments

ClearSight System

Device Noninvasive Hemodynamic Monitoring

Open in the dashboard

General payments

$46,372

798 payments

Research payments

$1,255,335

26 payments

Through program year 2020, $46,372 in general payments and $1,255,335 in research payments were reported against ClearSight System (Noninvasive Hemodynamic Monitoring).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $9,380 290
2020 Research $671,474 18
2019 General $36,992 508
2019 Research $583,862 8

Breakdown

Who paid General payments · program years 2019–2020
  1. Edwards Lifesciences Corporation $46,372 798 payments
Top recipients General payments · program year 2020
  1. Carlo Reyes Emergency Medicine · Thousand Oaks, CA $480 5% · 8 payments
  2. Muhammad Taqi Vascular Neurology · Palm Springs, CA $197 2% · 3 payments
  3. Matthew Beatty Emergency Medicine · Northridge, CA $146 2% · 1 payment
  4. John Kudirka Emergency Medicine · Thousand Oaks, CA $146 2% · 1 payment
  5. Evelyn Cardenas Emergency Medicine · Thousand Oaks, CA $146 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Anesthesiology $5,803 63% · 178 practitioners
  2. Emergency Medicine $1,082 12% · 8 practitioners
  3. Surgery $326 4% · 13 practitioners
  4. Critical Care Medicine Internal Medicine $250 3% · 4 practitioners
  5. Vascular Neurology Psychiatry & Neurology $197 2% · 1 practitioner

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $1,873 20% · 19 recipients
  2. Texas $1,654 18% · 46 recipients
  3. Florida $1,518 16% · 52 recipients
  4. Pennsylvania $1,395 15% · 39 recipients
  5. Georgia $429 5% · 12 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

798 general · 26 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record